Shailendra Koirala
Postdoctoral Scholar, Radiology
Bio
Shailendra Koirala is a Postdoctoral Scholar in the Department of Radiology at Stanford University, working at the intersection of molecular imaging, large-animal models (porcine), and translational research. His current research focuses on developing advanced MRI lymphangiography techniques using large-animal models to enable quantitative assessment of the lymphatic system and support translation of preclinical imaging approaches toward clinical applications.
Dr. Koirala has extensive experience in designing and optimizing imaging workflows, including MRI protocol development, quantitative image analysis (T1/T2, relaxivity), and longitudinal in vivo studies. His work integrates imaging, biology, and engineering, including targeted irradiation and surgical model development to study lymphatic function.
Prior to Stanford, he completed his Ph.D. in Chemistry and Biochemistry at the University of Texas at Dallas, where he developed fluorescent and MRI-based molecular probes for bacterial detection and engineered novel imaging platforms. His interdisciplinary background spans chemistry, microbiology, and in vivo systems, with a growing focus on clinical translation and radiology-driven research.
Honors & Awards
-
First-author Chemical Science article in RSC 2025 Most Popular Collection, Royal Society of Chemistry (RSC) (2025)
-
Mei Lein Fellowship, University of Texas at Dallas (2023)
-
Betty and Gifford Johnson Travel Award, University of Texas at Dallas (2022)
-
Best International Student Award, Southern Illinois University Edwardsville (2019)
-
Graduate Research Grant Award, Southern Illinois University Edwardsville (2018)
Boards, Advisory Committees, Professional Organizations
-
Reviewer, Chemical Engineering Journal (2022 - Present)
-
Secretary, Nepali Graduate Student Association at UTD (2023 - 2025)
Professional Education
-
Bachelor of Science, Kathmandu University (2015)
-
Master of Science, Southern Illinois Univ-Edwardsville (2020)
-
Doctor of Philosophy, University of Texas at Dallas (2025)
-
IRB/CITI Training, Stanford University, Clinical Research Compliance (2025)
-
Animal Research (IACUC) Training, Stanford University, Animal Research Compliance (2025)
-
MRI Safety Certification, Stanford University, Magnetic Resonance Imaging / Safety (2025)
Current Research and Scholarly Interests
My research focuses on developing advanced MRI-based lymphangiography methods for quantitative evaluation of the lymphatic system in large-animal (porcine) models. This work aims to bridge preclinical and clinical imaging by establishing reproducible imaging workflows, optimizing MRI protocols, and integrating biological, surgical, and imaging approaches.
I design and conduct longitudinal in vivo imaging studies, including MRI acquisition, quantitative data analysis (T1/T2 relaxivity), and interpretation of imaging-derived functional metrics. My work also involves targeted irradiation and surgical model development to study lymphatic disruption and recovery.
Through collaboration with radiologists, surgeons, and imaging scientists, I contribute to translational research initiatives, including ARPA-H Discovery Duo programs, with the goal of advancing imaging technologies toward clinical use.
Projects
-
MR Lymphangiography in Large-Animal (Porcine) Model, Stanford University (11/1/2025 - Present)
Development of a large-animal (porcine) model for MRI-based lymphangiography, integrating imaging, targeted irradiation, and surgical approaches to study lymphatic function. This work focuses on optimizing MRI workflows and enabling translational imaging studies bridging preclinical and clinical applications.
Location
Stanford, CA, USA
-
ARPA-H Discovery Duo: Translational Imaging Research, Stanford University (3/1/2026 - Present)
Contributing to ARPA-H Discovery Duo human subjects research focused on understanding stakeholder perspectives on MR lymphangiography. Responsibilities include conducting surveys and structured “voice session” interviews with patients, caregivers, and healthcare providers, recording and managing audio/video data, and supporting qualitative analysis. This work aims to incorporate patient and clinical stakeholder input into the development of imaging technologies and improve translational relevance.
Location
Stanford, CA, USA
-
Molecular Probe Development for Bacterial Imaging, University of Texas at Dallas (11/13/2024 - 11/13/2024)
Design and validation of fluorescent and MRI-based molecular probes for in vivo and in vitro detection of bacterial infections, combining chemistry, imaging, and biological systems to enable sensitive and selective imaging of intracellular pathogens.
Location
Richardson, TX, USA
All Publications
-
Fluorescent molecular probe for <i>in vivo</i> and <i>in vitro</i> targeting and imaging of an intracellular bacterial infection
CHEMICAL SCIENCE
2025; 16 (18): 7902-7911
Abstract
Intracellular bacterial infections are difficult to diagnose and treat because the host cells shelter the bacteria from molecular recognition by imaging agents, antibiotics, and the immune system. This problem arises when bladder epithelial cells are infected by uropathogenic Escherichia coli (UPEC)-one of the causative agents of urinary tract infection (UTI). UTIs are among the most common bacterial infections and a worldwide health concern. It is challenging to design molecular probes for intracellular UPEC imaging or targeted antibiotic treatment because the probe must possess multiple capabilities-it must permeate the host cell plasma membrane and selectively associate with the intracellular UPEC. Here, we report a "first-in-class" fluorescent probe called BactVue that is comprised of two structural components: a modified zinc(ii)-2,2'-dipicolylamine complex (Zn-Oxy-DPA) as the bacteria targeting unit and an appended near-infrared cyanine fluorophore that is hydrophilic but with a near-neutral electrostatic charge. The unique capacity of BactVue to penetrate infected bladder cells and stain intracellular UPEC was demonstrated by a series of in vitro and in vivo fluorescence imaging studies, including a mouse model of UTI. The results support the feasibility of incorporating BactVue into diagnostic near-infrared fluorescence imaging methods that visualize the location of infected bladder cells during active UTI.
View details for DOI 10.1039/d4sc05680a
View details for Web of Science ID 001457839400001
View details for PubMedID 40191126
View details for PubMedCentralID PMC11967239
-
TEMPO-conjugated tobacco mosaic virus as a magnetic resonance imaging contrast agent for detection of superoxide production in the inflamed liver.
Journal of materials chemistry. B
2024; 12 (13): 3273-3281
Abstract
Superoxide, an anionic dioxygen molecule, plays a crucial role in redox regulation within the body but is implicated in various pathological conditions when produced excessively. Efforts to develop superoxide detection strategies have led to the exploration of organic-based contrast agents for magnetic resonance imaging (MRI). This study compares the effectiveness of two such agents, nTMV-TEMPO and kTMV-TEMPO, for detecting superoxide in a mouse liver model with lipopolysaccharide (LPS)-induced inflammation. The study demonstrates that kTMV-TEMPO, with a strategically positioned lysine residue for TEMPO attachment, outperforms nTMV-TEMPO as an MRI contrast agent. The enhanced sensitivity of kTMV-TEMPO is attributed to its more exposed TEMPO attachment site, facilitating stronger interactions with water protons and superoxide radicals. EPR kinetics experiments confirm kTMV-TEMPO's faster oxidation and reduction rates, making it a promising sensor for superoxide in inflamed liver tissue. In vivo experiments using healthy and LPS-induced inflamed mice reveal that reduced kTMV-TEMPO remains MRI-inactive in healthy mice but becomes MRI-active in inflamed livers. The contrast enhancement in inflamed livers is substantial, validating the potential of kTMV-TEMPO for detecting superoxide in vivo. This research underscores the importance of optimizing contrast agents for in vivo imaging applications. The enhanced sensitivity and biocompatibility of kTMV-TEMPO make it a promising candidate for further studies in the realm of medical imaging, particularly in the context of monitoring oxidative stress-related diseases.
View details for DOI 10.1039/d3tb02765a
View details for PubMedID 38469725
-
An optimized purification protocol for enzymatically synthesized S-adenosyl-L-methionine (SAM) for applications in solution state infrared spectroscopic studies.
Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy
2024; 309: 123816
Abstract
S-adenosyl-L-methionine (SAM) is an abundant biomolecule used by methyltransferases to regulate a wide range of essential cellular processes such as gene expression, cell signaling, protein functions, and metabolism. Despite considerable effort, there remain many specificity challenges associated with designing small molecule inhibitors for methyltransferases, most of which exhibit off-target effects. Interestingly, NMR evidence suggests that SAM undergoes conformeric exchange between several states when free in solution. Infrared spectroscopy can detect different conformers of molecules if present in appreciable populations. When SAM is noncovalently bound within enzyme active sites, the nature and the number of different conformations of the molecule are likely to be altered from when it is free in solution. If there are unique structures or different numbers of conformers between different methyltransferase active sites, solution-state information may provide promising structural leads to increase inhibitor specificity for a particular methyltransferase. Toward this goal, frequencies measured in SAM's infrared spectra must be assigned to the motions of specific atoms via isotope incorporation at discrete positions. The incorporation of isotopes into SAM's structure can be accomplished via an established enzymatic synthesis using isotopically labeled precursors. However, published protocols produced an intense and highly variable IR signal which overlapped with many of the signals from SAM rendering comparison between isotopes challenging. We observed this intense absorption to be from co-purifying salts and the SAM counterion, producing a strong, broad signal at 1100 cm-1. Here, we report a revised SAM purification protocol that mitigates the contaminating salts and present the first IR spectra of isotopically labeled CD3-SAM. These results provide a foundation for isotopic labeling experiments of SAM that will define which atoms participate in individual molecular vibrations, as a means to detect specific molecular conformations.
View details for DOI 10.1016/j.saa.2023.123816
View details for PubMedID 38198991
-
A scalable synthesis of adjuvanting antigen depots based on metal-organic frameworks.
Chemical science
2024; 15 (8): 2731-2744
Abstract
Vaccines have saved countless lives by preventing and even irradicating infectious diseases. Commonly used subunit vaccines comprising one or multiple recombinant proteins isolated from a pathogen demonstrate a better safety profile than live or attenuated vaccines. However, the immunogenicity of these vaccines is weak, and therefore, subunit vaccines require a series of doses to achieve sufficient immunity against the pathogen. Here, we show that the biomimetic mineralization of the inert model antigen, ovalbumin (OVA), in zeolitic imidazolate framework-8 (ZIF-8) significantly improves the humoral immune response over three bolus doses of OVA (OVA 3×). Encapsulation of OVA in ZIF-8 (OVA@ZIF) demonstrated higher serum antibody titers against OVA than OVA 3×. OVA@ZIF vaccinated mice displayed higher populations of germinal center (GC) B cells and IgG1+ GC B cells as opposed to OVA 3×, indicative of class-switching recombination. We show that the mechanism of this phenomenon is at least partly owed to the metalloimmunological effects of the zinc metal as well as the sustained release of OVA from the ZIF-8 composite. The system acts as an antigen reservoir for antigen-presenting cells to traffic into the draining lymph node, enhancing the humoral response. Lastly, our model system OVA@ZIF is produced quickly at the gram scale in a laboratory setting, sufficient for up to 20 000 vaccine doses.
View details for DOI 10.1039/d3sc06734c
View details for PubMedID 38404371
View details for PubMedCentralID PMC10882496
-
In vivo biocompatibility of ZIF-8 for slow release via intranasal administration.
Chemical science
2023; 14 (21): 5774-5782
Abstract
Zeolitic imidazolate framework-8 (ZIF-8) is becoming popular in research for its potential in antigen protection and for providing a thermally stable, slow-release platform. While papers applying this material for immunological applications are aplenty in the literature, studies that explore the biosafety of ZIF-8 in mammals-especially when administered intranasally-are not well represented. We checked the body clearance of uncoated and ZIF-8-coated liposomes and observed that the release slowed as ZIF-8 is easily degraded by mucosal fluid in the nasal cavity. We delivered varying doses of ZIF-8, checked its short- and long-term effects on diagnostic proteins found in blood serum, and found no noticeable differences from the saline control group. We also studied their lung diffusing capacity and tissue morphology; neither showed significant changes in morphology or function.
View details for DOI 10.1039/d3sc00500c
View details for PubMedID 37265713
View details for PubMedCentralID PMC10231336
-
Rip it, stitch it, click it: A Chemist's guide to VLP manipulation.
Virology
2022; 577: 105-123
Abstract
Viruses are some of nature's most ubiquitous self-assembled molecular containers. Evolutionary pressures have created some incredibly robust, thermally, and enzymatically resistant carriers to transport delicate genetic information safely. Virus-like particles (VLPs) are human-engineered non-infectious systems that inherit the parent virus' ability to self-assemble under controlled conditions while being non-infectious. VLPs and plant-based viral nanoparticles are becoming increasingly popular in medicine as their self-assembly properties are exploitable for applications ranging from diagnostic tools to targeted drug delivery. Understanding the basic structure and principles underlying the assembly of higher-order structures has allowed researchers to disassemble (rip it), reassemble (stitch it), and functionalize (click it) these systems on demand. This review focuses on the current toolbox of strategies developed to manipulate these systems by ripping, stitching, and clicking to create new technologies in the biomedical space.
View details for DOI 10.1016/j.virol.2022.10.008
View details for PubMedID 36343470
-
Direct Correlation between Donor-Acceptor Distance and Temperature Dependence of Kinetic Isotope Effects in Hydride-Tunneling Reactions of NADH/NAD+ Analogues.
The Journal of organic chemistry
2021; 86 (11): 7500-7507
Abstract
Recent study of structural effects on primary kinetic isotope effects (1° KIEs) of H-transfer reactions in enzymes and solution revealed that a more rigid reaction system gave rise to a weaker temperature dependence of 1° KIEs, i.e., a smaller isotopic activation energy difference (ΔEa = EaD - EaH). This has been explained within the contemporary vibrationally assisted activated H-tunneling (VA-AHT) model in which rigidity is defined according to the density of donor-acceptor distance (DADTRS) populations at the tunneling ready state (TRS) sampled by heavy atom motions. To test the relationship between DADTRS and ΔEa in the model, we developed a computational method to obtain the TRS structures for H-transfer reactions. The method was applied to three hydride transfer reactions of NADH/NAD+ analogues for which the ΔEa's as well as secondary (2°) KIEs have been reported. The 2° KIEs computed from each TRS structure were fitted to the observed values to obtain the optimal TRSs/DADTRS's. It was found that a shorter DADTRS does correspond with a smaller ΔEa. This appears to support the VA-AHT model. Moreover, an analysis of hybridizations at the bent TRS structures shows that rehybridizations at the donor-acceptor centers are much more advanced than predicted from the classical mechanism. This implies that more orbital preparations are required for the nonclassical H-tunneling to take place.
View details for DOI 10.1021/acs.joc.1c00497
View details for PubMedID 34037396
-
Substituent Effects on Temperature Dependence of Kinetic Isotope Effects in Hydride-Transfer Reactions of NADH/NAD+ Analogues in Solution: Reaction Center Rigidity Is the Key.
Organic letters
2020; 22 (15): 5963-5967
Abstract
Substituent effects on the temperature dependence of primary kinetic isotope effects, characterized by ΔEa = EaD - EaH, for two series of the title reactions in acetonitrile were studied. The change from ΔEa ≈ 0 for a highly rigid system to ΔEa > 0 for systems with reduced rigidities was observed. The rigidities were controlled by the electronic and steric effects. This work replicates the observations in enzymes and opens a new research direction that studies structure-ΔEa relationship.
View details for DOI 10.1021/acs.orglett.0c02049
View details for PubMedID 32662653
https://orcid.org/0000-0001-6640-0072